Home > Riviste > Journal of Radiological Review > Fascicoli precedenti > Journal of Radiological Review 2021 March;8(1) > Journal of Radiological Review 2021 March;8(1):47-50

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

CASE REPORT   

Journal of Radiological Review 2021 March;8(1):47-50

DOI: 10.23736/S2723-9284.20.00055-X

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Embolization of hemorrhagic lymphangioleiomyomatotis-associated angiomyolipoma

Gianvito CANDITA 1 , Alessandro MARCUCCI 1, Chiara BOCCACCIO 1, Ilaria CARAMELLA 2

1 University of Pisa, Pisa, Italy; 2 University of Bologna, Bologna, Italy



The treatment of renal angiomyolipoma (AML) in female patients with a concurrent diagnosis of lymphangioleiomyomatosis (LAM) is a topical challenge in medicine. Renal AMLs occurring in patients with LAM are usually multiple, bilateral, fast-growing and present a high risk of life-threatening bleeding, whereby a nephron-sparing procedure is necessary in order to treat the lesion and to prevent the comparison of renal failure due to the treatment. The advent of selective artery embolization (SAE) represents a minimally invasive, effective and safe alternative to surgery or medical treatment.


KEY WORDS: Angiomyolipoma; Embolization, therapeutic; Lymphangioleiomyomatosis

inizio pagina